Sinovac's COVID-19 vaccine induces quick immune response: study
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday (November 18). Bryan Wood reports.
UP NEXT
UP NEXT
-
Pandoro Pudding
Australian Women's Weekly
-
Brussel Sprout Salad
Australian Women's Weekly
-
Potato Gnocchi
Australian Women's Weekly
-
Pfizer vaccine appears effective against coronavirus variant found in Britain - study
Reuters
-
European countries struggle to make most of Pfizer COVID-19 vaccine doses
Reuters
-
Supermarket chain Aldi to pay U.S. workers who get COVID-19 vaccination
Reuters
-
Brazil to begin vaccination campaign on Monday afternoon
Reuters
-
Brazil vaccinations start as country faces vaccine ingredient shortfall
Reuters
-
Brazil vaccinations start as country faces vaccine ingredient shortfall
Reuters
-
Vaccine nationalism puts world on brink of 'catastrophic moral failure': WHO chief
Reuters
-
UK says vaccine manufacturing is 'lumpy' but still on course for targets
Reuters
-
'Go for it,' says first person vaccinated in India's massive COVID-19 campaign
Reuters
-
'Go for it,' says first person vaccinated in India's massive COVID-19 campaign
Reuters
-
Vaccine shortages arise across U.S., halting inoculations in some places
Reuters
-
Trump administration accused of deception in pledging release of vaccine stockpile
Reuters
-
Fast-spreading UK coronavirus variant could be dominant in U.S. by March, CDC says
Reuters